Skip to content
value.today

Curemark LLC

Total raised
$78 M
12 rounds on record
Latest round
$1 M
Jan 2023
First round on record
Nov 2008
Today
Private
No later event on record

Funding rounds

12 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Curemark LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2023$1 MNo. 12Under $2 million

Curemark LLC: Raise no. 12, Jan 2023

Investors in this round

5 investors had bought by the notice of Mar 27, 2023: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $15 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Matthew Heil · Executive Officer
  • Afia Asamoah · Director
  • Kimball Duncan · Director
  • Leigh Morgan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 27, 2023. Read the notice at the SEC.

optionsSEC
Mar 2021$2 MNo. 11Under $2 million

Curemark LLC: Raise no. 11, Mar 2021

Investors in this round

2 investors had bought by the notice of Apr 14, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Matthew Heil · Executive Officer
  • Kimbell Duncan · Director
  • Leigh Morgan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 14, 2021. Read the notice at the SEC.

equitySEC
Aug 2019$5 MNo. 10$2 to $10 million

Curemark LLC: Raise no. 10, Aug 2019

Investors in this round

1 investor had bought by the notice of Sep 11, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $50 M offered; $45 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Jzaneen Lalani · Executive Officer
  • Matthew Heil · Executive Officer
  • Jennifer Frist · Director
  • Kimbell Duncan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Ceo. Source: SEC Form D, newest notice filed Sep 11, 2019. Read the notice at the SEC.

equitySEC
Apr 2018$2 MNo. 9Under $2 million

Curemark LLC: Raise no. 9, Apr 2018

Investors in this round

1 investor had bought by the notice of Apr 26, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
$1,000,000
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Jzaneen Lalani · Executive Officer
  • Matthew Heil · Executive Officer
  • Eric Hermann · Director
  • Jennifer Frist · Director
  • Justin Stebbing · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager, CEO. Source: SEC Form D, newest notice filed Apr 26, 2018. Read the notice at the SEC.

optionsSEC
Jan 2018$3 MNo. 8$2 to $10 million

Curemark LLC: Raise no. 8, Jan 2018

Investors in this round

1 investor had bought by the notice of Jan 29, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $80 M offered; $77 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Jzaneen Lalani · Executive Officer
  • Matthew Heil · Executive Officer
  • Eric Hermann · Director
  • Jennifer Frist · Director
  • Justin Stebbing · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager, CEO. Source: SEC Form D, newest notice filed Jan 29, 2018. Read the notice at the SEC.

equitySEC
Mar 2017$3 MNo. 7$2 to $10 million

Curemark LLC: Raise no. 7, Mar 2017

Investors in this round

2 investors had bought by the notice of Mar 20, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $150 M offered; $147 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Jzaneen Lalani · Executive Officer
  • Matthew Heil · Executive Officer
  • Eric Hermann · Director
  • Jennifer Frist · Director
  • Justin Stebbing · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager, CEO. Source: SEC Form D, newest notice filed Mar 20, 2017. Read the notice at the SEC.

equitySEC
Jun 2015$20 MNo. 6$10 to $50 million

Curemark LLC: Raise no. 6, Jun 2015

Investors in this round

2 investors had bought by the notice of Jul 13, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $30 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$800,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director
  • Matthew Heil · Executive Officer
  • Eric Herman · Director
  • Kimball Duncan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager. Source: SEC Form D, newest notice filed Jul 13, 2015. Read the notice at the SEC.

optionsSEC
Dec 2014$5 MNo. 5$2 to $10 million

Curemark LLC: Raise no. 5, Dec 2014

Investors in this round

1 investor had bought by the notice of Jan 14, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $18 M offered; $13 M still to sell
Smallest investment taken
$1,000,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,575,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director · Manager of the LLC
  • Matthew Heil · Executive Officer
  • Eric Herman · Director · Manager of the LLC
  • Kimball Duncan · Director · Manager of the LLC
  • Klaus Kleinfeld · Director · Manager of the LLC

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager. Source: SEC Form D, newest notice filed Jan 14, 2015. Read the notice at the SEC.

debt, optionsSEC
Jun 2013$19 MNo. 4$10 to $50 million

Curemark LLC: Raise no. 4, Jun 2013

Investors in this round

66 investors had bought by the notice of Jan 14, 2014: 66 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $20 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,850,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director · Manager of the LLC
  • Matthew Heil · Executive Officer
  • Eric Herman · Director · Manager of the LLC
  • Kimball Duncan · Director · Manager of the LLC
  • Klaus Kleinfeld · Director · Manager of the LLC

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$11,819,072 was new cash investments and $6,933,394 was the conversion of convertible notes and cancellation of related warrants (the notes and warrants were issued in the offering described in the Issuer's March 2012 Form D as amended in February 2013).”

Signed by Joan Fallon, Manager. Source: SEC Form D, newest notice filed Jan 14, 2014. Read the notice at the SEC.

equitySEC
Feb 2012$6 MNo. 3$2 to $10 million

Curemark LLC: Raise no. 3, Feb 2012

Investors in this round

37 investors had bought by the notice of Feb 5, 2013: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $15 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director · Manager of the LLC
  • Matthew Heil · Executive Officer
  • Eric Herman · Director · Manager of the LLC
  • Kimball Duncan · Director · Manager of the LLC
  • Klaus Kleinfeld · Director · Manager of the LLC

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager. Source: SEC Form D and 1 amendment, newest notice filed Feb 5, 2013. Read the notice at the SEC.

debt, optionsSEC
Jul 2010$5 MNo. 2$2 to $10 million

Curemark LLC: Raise no. 2, Jul 2010

Investors in this round

3 investors had bought by the notice of Jul 29, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$800,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Elisa Zinberg · Executive Officer
  • Joan Fallon · Executive Officer, Director · Manager of LLC
  • Matthew Heil · Executive Officer
  • Eric Herman · Director · Manager of LLC
  • Kimball Duncan · Director · Manager of LLC
  • Klaus Kleinfeld · Director · Manager of LLC

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager. Source: SEC Form D, newest notice filed Jul 29, 2010. Read the notice at the SEC.

equitySEC
Nov 2008$6 MNo. 1$2 to $10 million

Curemark LLC: Raise no. 1, Nov 2008

Investors in this round

110 investors had bought by the notice of Jun 19, 2009: 110 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $7 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$225,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joan Fallon · Executive Officer, Director · Manager of LLC

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joan Fallon, Manager. Source: SEC Form D, newest notice filed Jun 19, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Curemark LLC chose not to state its revenue in its newest notice of a funding round (Mar 2023).

    SEC Form D · Mar 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2023

That is all the official record says: Curemark LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Curemark LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 12 rounds above had up to 110 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Curemark LLC
NameRoleNamed in
Joan FallonExecutive officerMar 2023
Matthew HeilExecutive officerMar 2023
Jzaneen LalaniExecutive officerSep 2019
Elisa ZinbergExecutive officerJul 2010
Afia AsamoahDirectorMar 2023
Joan FallonDirectorMar 2023
Kimball DuncanDirectorMar 2023
Leigh MorganDirectorMar 2023
Kimbell DuncanDirectorApr 2021
Jennifer FristDirectorSep 2019
Eric HermannDirectorApr 2018
Justin StebbingDirectorApr 2018
Eric HermanDirectorJul 2015
Klaus KleinfeldManager of the LLCJan 2015